Table 3 Parameters associated with ECMO treatment and outcome

Respiratory and circulatory parameters

 ARDS

30

36

83.4

 Horovitz (mean, range)

68.1 (30.0–131.0)

16

 Cardiac failure

9

34

26.5

 Catecholamine treatment

15

16

93.8

Course of ECMO treatment

 VV V-V^a

31

37

83.7

 VA V-A^a

9

37

24.3

 VVA VA-V^a

2

37

5.4

 VVA VV-A ^a

1

37

2.7

 LFPPV-ECCO₂R

2

37

5.4

 Implantation after diagnosis (days, median, IQR)

5 (1–12)

9

 Implantation after installation of TB treatment (days, median, IQR)

9 (2.5–63)

7

 Duration of ECMO therapy (days, median, IQR)

10.0 (7.0–28.0)

33

 Time of ventilation (days, median, IQR)

33 (11.5–57.0)

19

 Time in ICU (days, mean, range)

45.1 (12–114.0)

10

 Total observation time (days, median, IQR)

46.0 (10.8–250.9)

33

Outcome

 Complications of ECMO therapy

17

35

48.6

  Alveolar haemorrhage

4

17

23.5

  Pneumothorax

2

17

11.7

  Intracranial haemorrhage

2

17

11.7

  Disconnection/Failure of pump

3

17

17.6

  Thrombocytopenia

4

17

23.5

  Bleeding other

5

17

29.4

 Long term ventilation after ECMO necessary

2

28

7.1

 Deceased

8

43

18.6

 Deceased under ECMO therapy

7

43

16.3

 Time to death (mean, IQR)

21.2 (12–39)

5